Iyini i-Liposomal NAD+ Powder? Umhlahlandlela Ophelele Wemikhiqizo Eyengeziwe Yesikhathi Eside

Okwabanikazi bomkhiqizo wezithasiselo, ososayensi bokwakha, nabaphathi bokuthenga abahlolayoliposomal NAD+ powderngemikhiqizo yabo{0}elandelayo yokuphila isikhathi eside, ukuqonda isayensi yalesi sithako kubalulekile ekutholeni ulwazi kanye nezinqumo zokuthuthukisa umkhiqizo. I-NAD+ (i-nicotinamide adenine dinucleotide) iyi-coenzyme ebalulekile etholakala kuwo wonke amangqamuzana aphilayo, ibalulekile ekukhiqizeni amandla eselula, ukulungisa i-DNA, futhi njenge-cofactor yama-sirtuin-ama-enzyme alawula impilo yeselula nokusebenza kwe-metabolic, okuyizindawo zocwaningo olusebenzayo ekugugeni okunempilo. Kodwa-ke, izithasiselo ezijwayelekile zomlomo ze-NAD+ ngokomlando ziye zabhekana nomkhawulo obalulekile: I-NAD+ ikhombisa ukufinyeleleka kwe-membrane okulinganiselwe ngenxa yobukhulu bayo be-molecular kanye ne-polarity, okufaka isandla ekukhawulweni kwe-bioavailability yomlomo kanye nokuwohloka kwe-extracellular.I-Liposomal NAD+ibhekana nale nselele ngokusebenzisa i-phospholipid encapsulation, enikeza isu elithuthukisiwe lokulethwa kwemikhiqizo ethuthukisa ukwakheka kokuphila isikhathi eside kwe-premium.

 

 

 

I-NAD+ iyi-coenzyme ebamba iqhaza ekuphenduleni okuningi kwe-metabolic, ikakhulukazi leyo ebandakanyeka ekukhiqizweni kwamandla. Itholakala ngezindlela ezimbili-i-NAD+ ne-NADH-ezishintshayo ekuphenduleni kwe-redox. I-NAD+ ibalulekile ekuphefumuleni kwamaselula nasekukhiqizeni i-ATP, uhlobo lwemali oluyinhloko lwamaseli. Ekuphefumuleni kwamaselula, i-NAD+ yamukela ama-electron asuka kuma-molecule afana ne-glucose ngesikhathi se-glycolysis kanye nomjikelezo we-citric acid, iwadlulisela ochungechungeni lwezokuthutha lwama-electron lapho kukhiqizwa khona i-ATP.

Ngale kwe-energy metabolism, i-NAD+ idlala indima ebalulekile ezindleleni zokulungisa i-DNA. Ama-enzyme abandakanyeka ekulungiseni i-DNA, njenge-PARPs (i-poly ADP-ribose polymerases), adinga i-NAD+ njenge-substrate. I-NAD+ futhi iyi-cofactor ebalulekile yama-sirtuin, umndeni wama-enzyme alawula ukubonakaliswa kofuzo, ukulungiswa kwe-DNA, kanye ne-metabolism. I-NAD+ ingathonya ngokuqondile nangokungaqondile imisebenzi eminingi ebalulekile yamaselula, okuhlanganisa izindlela ze-metabolic, ukulungiswa kwe-DNA, ukulungiswa kabusha kwe-chromatin, ukuvela kwamaselula nokusebenza kwamangqamuzana omzimba omzimba.

 

 

Ucwaningo oluningi lubonise ukuthi amazinga e-NAD+ yeselula ngokuvamile ehla ngokuguga okulandelanayo. Lokhu kuncipha kubonakala kudlala indima ebalulekile ekwakhiweni kokungasebenzi kahle kwe-metabolic kanye{2}}nezimo ezihlobene nobudala.

Izindlela ezibangela lokhu kwehla ziningi:

• Ukusetshenziswa okungeziwe kwe-NAD+: Umsebenzi wokusebenzisa i-NAD+-ama-enzyme afana ne-CD38 nama-PARPs uyenyuka ngokuya ngeminyaka. Amazinga e-CD38 ayakhuphuka ngesikhathi sokuguga futhi anegalelo elikhulu ekuncipheni kweminyaka{{4}okuhlobene ne-NAD+.
• Kuncishiswe ukuhlanganisa: Ukubonakaliswa okuncishisiwe kwe-enzyme ye-salvage pathway eyinhloko i-nicotinamide phosphoribosyltransferase (NAMPT) kubikwe kwezinye izicubu ezinobudala.
• Ukungasebenzi kahle kwe-Mitochondrial: Ubudala-ukukhubazeka okuhlobene kwe-mitochondrial kunomthelela ekwehleni kwe-NAD+.
• Ukulimala nokuvuvukala kwe-DNA: Lezi zinqubo-ezihlobene neminyaka yobudala ziqhuba ukusetshenziswa kwe-NAD+ nge-PARP kanye nokwenza kusebenze i-CD38.

Ukuncipha kwe-NAD+ kuthinta izimpawu eziningi zokuguga, okwenza ukubuyiselwa kwe-NAD+ kube okuhlosiwe okuthakaselayo okubalulekile kwezesayensi nokuhweba.

 

 

I-NAD+ inesisindo samangqamuzana esikhulu (663.43 Da) kanye nesakhiwo esiyinkimbinkimbi esinikela ekungeneni kolwelwesi olulinganiselwe. I-NAD+ futhi ayizinzile ngokwangaphakathi, yehlisa isithunzi kalula emazingeni okushisa azungezile noma aphakeme, okuphinde kubeke imingcele ekusetshenzisweni kwayo kumaphilisi namaphilisi ajwayelekile.

Ubuchwepheshe bokulethwa kwe-Liposomal bubhekana nalezi zinselele ngokusebenzisa i-phospholipid encapsulation. Ama-molecule e-NAD+ ambozwe ngaphakathi kwama-bilayers e-phospholipid{2}}ngokuvamile atholakala ku-sunflower okungeyona-i-GMO} noma i-lecithin ye-soy{4}}akha ama-microscopic vesicles ngokuvamile phakathi kwebanga le-nanoscale, kuye ngobuchwepheshe bokubunjwa.

Isebenza kanjani i-Liposomal Encapsulation

Indlela	Incazelo
Ukuvikelwa ngesikhathi sokuthutha	I-lipid bilayer ivikela i-NAD+ ekonakalisweni komgudu wamathumbu, iwuvikele ku-asidi yesisu kanye nama-enzyme okugaya.
Ukuthatha amaselula okuthuthukisiwe	Ngenxa yokuthi ukwakheka kwe-lipid kufana nolwelwesi lwamaseli lwemvelo, ama-liposomes angahlangana namaseli e-mucosa emathunjini ngokuhlangana kwe-membrane noma izindlela ze-endocytosis.
Kwehliswe{0}}i-pass metabolism yokuqala	Isakhiwo se-liposomal singase sinciphise izinga-lokudlula kwemetabolism ngokwenza lula ukumuncwa ngemizila ye-lymphatic yamathumbu, okungase kuvumele ingxenye enkulu yama-molecule e-NAD+ angaguquki ukuthi afinyelele ukujikeleza kwesistimu.

 

 

Idatha Yomtholampilo Wabantu

Ucwaningo olungelona-okungahleliwe lwe-crossover olushicilelwe ngo-2026 lwaphenya imiphumela ye-oral liposomal NAD+ supplementation kumazinga we-intracellular NAD+ kubantu. Abahlanganyeli abayishumi nane bathathe i-1,000 mg ye-liposomal NAD+ nsuku zonke amasonto amabili. Ngemuva kwezinsuku eziyi-14, ababambiqhaza bathole ukukhuphuka okuphakathi kwama-64% kumazinga we-NAD+ we-intracellular uma kuqhathaniswa nesisekelo (p.<0.01). Although encouraging, larger randomized controlled trials are needed to confirm these findings.

Ukuthuthukiswa Kwe-Bioavailability

I-Liposomal encapsulation ikhonjiswe ukuthuthukisa kakhulu i-bioavailability ye-NAD+ uma kuqhathaniswa namalungiselelo aqinile ajwayelekile ezifundweni ze-pharmacokinetic. Idatha yokuqala yabantu kanye nophenyo lwe-pharmacokinetic luphakamisa ukuthi amazinga e-plasma kanye ne-intracellular NAD+ ahlala ephakanyisiwe isikhathi eside kulandela ukuphathwa kwe-liposomal kunokwakheka okuvamile.

Ukuvikelwa Kwezicubu

I-Liposome encapsulation ithuthukisa ukulethwa kwe-intracellular yama-molecule amakhulu, akhokhisiwe nama-substrates asengozini yokuwohloka kwama-enzyme angaphandle. Ucwaningo lubonise ukuthi ukwelashwa nge-liposome{1}}i-encapsulated NAD+ kusiza ukuvikela amaseli e-endothelial womuntu kusukela ekuhlulekeni kwamandla kumamodeli we-cell culture.

 

 

Isici	I-NAD+ evamile	I-NAD+ Precursors (NMN, NR)	I-Liposomal NAD+
I-Bioavailability	Impofu kakhulu; ukuwohloka okusheshayo emgudwini wokugaya ukudla	Okulingene; ukuguquguquka ngokwesandulela kanye ne-metabolism yomuntu ngamunye	Kuthuthukiswe kakhulu ngokuvikela i-lipid bilayer
Indlela	I-NAD eqondile+-kodwa ayimuncwe kahle	Idinga ukuguqulwa kwe-enzymatic ku-NAD+	I-NAD+ eqondile ilethwa ngama-protective liposomal vesicles
Ukuzinza	Ayizinzile; kwehlisa izinga lokushisa endaweni	Iyahlukahluka ngokuya ngesitoreji kanye ne-matrix	Kuthuthukiswe nge-phospholipid encapsulation
Ukuthatha iselula	Ukungena kwe-membrane okulinganiselwe	Isandulela-sincike ngezithuthi ezithile	Kwenziwa nge-endocytosis kanye ne-membrane fusion

 

 

 

Imibiko eyahlukene yezimboni ikhombisa ukukhula okuqinile emkhakheni wezinsiza ze-NAD+, oqhutshwa ukwanda kokuqwashisa kwabathengi ngempilo yamaselula nokuguga okunempilo. Imakethe yemikhiqizo ye-nicotinamide adenine dinucleotide ebanzi ikhombise ukwanda okungaguquki ezifundeni eziningi.

 

Izindawo Ezibalulekile Zokufaka Isicelo Se-Liposomal NAD+ Powder

Isicelo	I-Target Demographic	Amafomethi Omkhiqizo
Izithako zokuphila isikhathi eside	Abantu asebekhulile abaphathelene nokuguga okunempilo	Amaphilisi, amaphilisi, amaphakethe wenduku
Amandla namandla ahlanganayo	Abantu abadala abakhuthele, ochwepheshe	Ama-capsules, ama-liquid shots
Imikhiqizo yezempilo yamaselula	Ezempilo{{0}abathengi abagxile ekuvuseleleni amaselula	Iziphuzo ezisebenzayo, izimpushana
Imigqa yokuphila kahle kwe-Premium	Izinhlobo-ezisezingeni eliphezulu zokungezelela	Ukwakheka ngokwezifiso

I-Liposomal NAD+ inikeza amabhrendi e-B2B ithuba lokubeka imikhiqizo engxenyeni ephambili yemakethe yokuphila isikhathi eside, ehlukanisa{2}}ngobuchwepheshe bokulethwa obusekelwayo besayensi.

 

 

Ngochwepheshe bokuthenga, ukukhetha okulungilei-liposomal NAD+ umphakeli we-powderidinga ukuhlola amapharamitha angukhiye ambalwa:

Imibandela Yokuhlola Abahlinzeki Bempahla Ebalulekile

Ipharamitha	Okufanele Uqinisekise
Okuqukethwe kwe-NAD+	50%, 70%, noma imininingwane yangokwezifiso nge-HPLC eqinisekisiwe
Umthombo we-Phospholipid	Okungeyona-i-GMO sunflower noma i-soy lecithin
Ukusebenza kahle kwe-encapsulation	Umhlinzeki{0}}uchaze ukusebenza kahle kwe-encapsulation okuqinisekisiwe okusekelwa ukuhlola kokuhlaziya
Usayizi wezinhlayiya	Ngaphakathi kwebanga le-nanoscale elinenkomba ephansi ye-polydispersity (PDI)
Inqubo yokukhiqiza	I-high{{0}pressure homogenization noma i-microfluidization
Idatha yokuzinza	Impilo yeshelufu ebhalwe phansi ngaphansi kwezimo zokulondoloza ezinconyiwe
Izitifiketi zekhwalithi	cGMP, ISO 22000, FSSC 22000, HACCP
Amadokhumenti	Iqoqo-i-COA ethile, i-TDS, i-MSDS, imibiko yokuzinza

Izinketho Zefomethi Yomkhiqizo

I-Liposomal NAD+ itholakala ngamafomethi amaningi ukuze ihlangabezane nezidingo-zomkhiqizo oqediwe ohlukahlukene:

• Friza-impushana ye-liposomal eyomisiwe- Izinzile ukuze kufakwe i-encapsulation kumaphilisi, amaphilisi, namaphakethe wenduku
• Fafaza-impushana ye-liposomal eyomisiwe- Ifanele izingxube nokudla okusebenzayo
• Ukumiswa kwe-liposomal ye-Liquid– Ilungele-ukusetshenziselwa-iziphuzo nezithako eziwuketshezi

 

 

Q: Uyini umehluko phakathi kwe-liposomal NAD+ kanye ne-NAD+ precursors njenge-NMN noma i-NR?
Izandulela ze-NAD+ (i-NMN ne-NR) zidinga ukuguqulwa kwe-enzymatic ku-NAD+ ngaphakathi komzimba. I-Liposomal NAD+ iletha i-NAD+ ngendlela ehlanganisiwe edizayinelwe ukuthuthukisa ukuzinza nokusekela ukulethwa komlomo, ngaphandle kokuthembela esilinganisweni-sokukhawulela ukuguqulwa kwama-enzyme.

Q: Bubonisani ubufakazi bomtholampilo nge-liposomal NAD+?
Ucwaningo lwango-2026 olungeyona{1}}okungahleliwe lubonise ukuthi u-1,000 mg we-liposomal NAD+ nsuku zonke ukhuphule amazinga e-NAD+ e-intracellular ngaphezulu kuka-64% ngemva kwezinsuku eziyi-14 (p<0.01). This study provides preliminary clinical evidence that oral liposomal NAD+ supplementation can significantly raise intracellular NAD+ levels in humans. Larger randomized controlled trials are needed to confirm these findings.

Q: Yiziphi izici okufanele abathengi bazicele ngobuningi be-liposomal NAD + powder?
Abathengi kufanele bacele okuqukethwe kwe-NAD+ (ngokuvamile okungu-50% noma u-70%), umthombo we-phospholipid (ubhekilanga noma isoya), idatha ye-encapsulation, ukusatshalaliswa kosayizi wezinhlayiyana nge-dynamic light scattering (DLS), polydispersity index (PDI), i-COA yenqwaba{3}},{4}}idatha yokuzinza yesikhathi sangempela, nezitifiketi zekhwalithi.

Q: Kufanele igcinwe kanjani i-liposomal NAD + powder?
Friza-izimpushana ze-liposomal ezomisiwe ngokuvamile zigcina uzinzo izinyanga ezingu-24 uma zigcinwe zivaliwe endaweni epholile, eyomile ekude nokukhanya okuqondile, ukushisa, kanye nomswakama. Ukumiswa koketshezi kungase kudinge isiqandisi.

Q: Yiziphi izitifiketi zekhwalithi okufanele umphakeli we-liposomal NAD+ azibambe?
Okungenani, bheka i-cGMP, i-ISO 22000 noma i-FSSC 22000, nesitifiketi se-HACCP. Kuya ngemakethe oyihlosile, izitifiketi ze-Kosher neze-Halal nazo zingadingeka ukuze kusatshalaliswe umhlaba wonke.

 

 

I-Liposomal NAD+ powder imele indlela yokulethwa ethuthukisiwe esigabeni sokwengeza impilo ende, ebhekana nemikhawulo ye-bioavailability eye yavimbela ngokomlando ukwakheka okuvamile kwe-NAD+. Ngokufaka i-phospholipid encapsulation, ubuchwepheshe buvikela i-NAD+ ekonakalisweni kwamathumbu, kusiza ukutholwa kwamaselula, futhi kubonise ukwanda okukhuthazayo kwamazinga e-NAD+ e-intracellular ocwaningweni lwabantu bokuqala. Kudingeka ezinye izifundo zomtholampilo ezingahleliwe ukuze kuqinisekiswe lokhu okutholakele.

Kubathengi be-B2B-abadidiyeli, abaqondisi be-R&D, abaphathi bokuthengwa kwempahla, nabanikazi bomkhiqizo{2}}lokhu kuhumushela ezinzuzweni ezibambekayo zezentengiselwano: amaphothifoliyo omkhiqizo ahlukene, isayensi{3}}ukuthuthukiswa kokubunjwa okunolwazi, ukuma kwemakethe ye-premium, nobudlelwano obuthembekile bochungechunge lokuhlinzeka. Emkhakheni wemakethe okhulayo, i-liposomal NAD+ inika amandla amabhrendi ukuthi alethe lokho okulindelwe ngabathengi ukuze kube nobufakazi{{6}obusekelwe, izithako ezinempilo ezitholakalayo zokuguga ngenkathi yakhela inzuzo yokuncintisana.

 

Ingabe usukulungele ukuthuthukisa ukwakheka kwakho kwe-premium liposomal NAD+?Ithimba lethu lobuchwepheshe liyatholakala ukuze lisekele ukuthuthukiswa komkhiqizo wakho kusukela kumqondo kuya ekuqalisweni kwezentengiso. Ochwepheshe bethu bokwakhiwa basekela ukukhethwa kwezithako, ukuthuthukiswa kokwakhiwa, ukukhiqizwa kokuhlola, amaphrojekthi we-OEM/ODM, kanye nemibhalo yokulawula yezimakethe zamazwe ngamazwe.

• Cela isampulaokokuhlola{0}kwasendlini kanye nezivivinyo zokwakha
• Cela iphakethe lamadokhumenti obuchwepheshe(COA, izifundo zokuzinza, ukuhlaziywa kosayizi wezinhlayiyana)
• Buza mayelana nokucaciswa ngokwezifiso(ukugxila, usayizi wezinhlayiya, izinketho ze-excipient)
• Hlela ukubonisana kwezobuchwepheshenososayensi bethu bokwakha

Xhumana nethimba lethu le-B2B namuhla ukuze uxoxe ngezidingo zakho zokuthola usizo. I-imeyili:liu@wellgreenxa.com

 

 

1. I-Covarrubias AJ, i-Perrone R, i-Grozio A, i-Verdin E. NAD+ i-metabolism kanye nezindima zayo ezinqubweni zamaselula ngesikhathi sokuguga.I-Nat Rev Mol Cell Biol. 2021;22(2):119-141. doi:10.1038/s41580-020-00313-x
2. I-Verdin E. NAD+ ekugugeni, i-metabolism, kanye ne-neurodegeneration.Isayensi. 2015;350(6265):1208-1213. doi:10.1126/science.aac4854
3. Yoshino J, Baur JA, Imai SI. I-NAD+ Intermediates: I-Biology kanye Namandla Okwelapha e-NMN ne-NR.I-Metab Yeseli. 2018;27(3):513-528. doi:10.1016/j.cmet.2017.11.002
4. Rajman L, Chwalek K, Sinclair DA. Amandla Okwelapha e-NAD-Athuthukisa Ama-Moleculi: Ubufakazi be-In Vivo.I-Metab Yeseli. 2018;27(3):529-547. doi:10.1016/j.cmet.2018.02.011
5. U-Blair E, u-Miller A, uMcDonald R. Ukhushulwe Amazinga e-Intracellular NAD+ Nge-Oral Supplementation With a Novel Liposomal Delivery Method: A Non{2}}Non{2}}I-Randomized Crossover Study.I-NDNR. 2026
6. Ukulawulwa kwe-NAD + metabolism ekugugeni nasekuguleni.I-Metabolism. 2022;126:154923. doi:10.1016/j.metabol.2021.154923
7. Wilson N, et al. I-autophagy-i-NAD axis ekuphileni isikhathi eside nezifo.I-Trends Cell Biol. 2023;33(9):788-802. doi:10.1016/j.tcb.2023.02.004
8. I-Canto C, i-Menzies KJ, i-Auwerx J. NAD+ i-metabolism kanye nokulawulwa kwe-homeostasis yamandla: isenzo sokulinganisa phakathi kwe-mitochondria ne-nucleus. I-Metabolism Yeseli.